vs
INSEEGO CORP.（INSG）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是INSEEGO CORP.的1.4倍（$69.8M vs $48.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 1.0%，领先383.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 0.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 13.6%）
Inseego Corp是全球领先的5G及物联网解决方案提供商，主打移动热点、边缘计算设备及云端设备管理平台产品，客户覆盖全球范围内的电信运营商、企业及公共部门。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
INSG vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$48.4M
营收增速更快
RIGL
高出20.5%
0.6%
净利率更高
RIGL
高出383.1%
1.0%
两年增速更快
RIGL
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.4M | $69.8M |
| 净利润 | $469.0K | $268.1M |
| 毛利率 | 42.2% | 91.5% |
| 营业利润率 | 2.7% | 33.2% |
| 净利率 | 1.0% | 384.0% |
| 营收同比 | 0.6% | 21.2% |
| 净利润同比 | 182.9% | 1769.2% |
| 每股收益（稀释后） | $-0.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INSGRIGL
| Q4 25 | $48.4M | $69.8M | ||
| Q3 25 | $45.9M | $69.5M | ||
| Q2 25 | $40.2M | $101.7M | ||
| Q1 25 | $31.7M | $53.3M | ||
| Q4 24 | $48.1M | $57.6M | ||
| Q3 24 | $54.0M | $55.3M | ||
| Q2 24 | $51.6M | $36.8M | ||
| Q1 24 | $37.5M | $29.5M |
净利润INSGRIGL
| Q4 25 | $469.0K | $268.1M | ||
| Q3 25 | $1.4M | $27.9M | ||
| Q2 25 | $507.0K | $59.6M | ||
| Q1 25 | $-1.6M | $11.4M | ||
| Q4 24 | $-566.0K | $14.3M | ||
| Q3 24 | $9.0M | $12.4M | ||
| Q2 24 | $624.0K | $-1.0M | ||
| Q1 24 | $-4.5M | $-8.2M |
毛利率INSGRIGL
| Q4 25 | 42.2% | 91.5% | ||
| Q3 25 | 41.6% | 93.2% | ||
| Q2 25 | 41.1% | 95.6% | ||
| Q1 25 | 47.3% | 91.7% | ||
| Q4 24 | 37.3% | 89.9% | ||
| Q3 24 | 34.8% | 85.5% | ||
| Q2 24 | 36.4% | 92.4% | ||
| Q1 24 | 35.3% | 93.1% |
营业利润率INSGRIGL
| Q4 25 | 2.7% | 33.2% | ||
| Q3 25 | 4.7% | 40.9% | ||
| Q2 25 | 3.2% | 60.1% | ||
| Q1 25 | -1.3% | 23.9% | ||
| Q4 24 | 3.7% | 28.9% | ||
| Q3 24 | 1.9% | 25.4% | ||
| Q2 24 | 3.6% | 1.2% | ||
| Q1 24 | -7.9% | -23.6% |
净利率INSGRIGL
| Q4 25 | 1.0% | 384.0% | ||
| Q3 25 | 3.1% | 40.2% | ||
| Q2 25 | 1.3% | 58.6% | ||
| Q1 25 | -5.0% | 21.5% | ||
| Q4 24 | -1.2% | 24.9% | ||
| Q3 24 | 16.6% | 22.5% | ||
| Q2 24 | 1.2% | -2.8% | ||
| Q1 24 | -11.9% | -27.9% |
每股收益（稀释后）INSGRIGL
| Q4 25 | $-0.02 | $14.11 | ||
| Q3 25 | $0.03 | $1.46 | ||
| Q2 25 | $-0.03 | $3.28 | ||
| Q1 25 | $-0.16 | $0.63 | ||
| Q4 24 | $0.62 | $0.82 | ||
| Q3 24 | $-0.06 | $0.70 | ||
| Q2 24 | $-0.02 | $-0.06 | ||
| Q1 24 | $-0.44 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-4.0M | $391.5M |
| 总资产 | $93.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资INSGRIGL
| Q4 25 | $24.9M | $155.0M | ||
| Q3 25 | $14.6M | $137.1M | ||
| Q2 25 | $13.2M | $108.4M | ||
| Q1 25 | $35.1M | $77.1M | ||
| Q4 24 | $39.6M | $77.3M | ||
| Q3 24 | $12.0M | $61.1M | ||
| Q2 24 | $49.0M | $49.1M | ||
| Q1 24 | $12.3M | $49.5M |
总债务INSGRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益INSGRIGL
| Q4 25 | $-4.0M | $391.5M | ||
| Q3 25 | $-7.7M | $117.6M | ||
| Q2 25 | $-10.5M | $81.9M | ||
| Q1 25 | $-13.0M | $18.6M | ||
| Q4 24 | $-12.9M | $3.3M | ||
| Q3 24 | $-85.1M | $-14.6M | ||
| Q2 24 | $-101.8M | $-29.9M | ||
| Q1 24 | $-105.6M | $-31.7M |
总资产INSGRIGL
| Q4 25 | $93.8M | $513.6M | ||
| Q3 25 | $85.8M | $242.5M | ||
| Q2 25 | $83.1M | $206.7M | ||
| Q1 25 | $93.0M | $176.0M | ||
| Q4 24 | $100.0M | $164.0M | ||
| Q3 24 | $113.4M | $139.4M | ||
| Q2 24 | $149.6M | $128.4M | ||
| Q1 24 | $122.1M | $126.5M |
负债/权益比INSGRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | — |
| 自由现金流率自由现金流/营收 | 24.0% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | 25.50× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $6.5M | — |
8季度趋势，按日历期对齐
经营现金流INSGRIGL
| Q4 25 | $12.0M | $22.0M | ||
| Q3 25 | $3.2M | $24.0M | ||
| Q2 25 | $-4.5M | $30.5M | ||
| Q1 25 | $-3.5M | $-893.0K | ||
| Q4 24 | $-14.2M | $14.5M | ||
| Q3 24 | $14.8M | $21.7M | ||
| Q2 24 | $27.6M | $302.0K | ||
| Q1 24 | $5.2M | $-5.0M |
自由现金流INSGRIGL
| Q4 25 | $11.6M | — | ||
| Q3 25 | $3.1M | — | ||
| Q2 25 | $-4.7M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-14.3M | — | ||
| Q3 24 | $14.8M | — | ||
| Q2 24 | $27.6M | — | ||
| Q1 24 | — | — |
自由现金流率INSGRIGL
| Q4 25 | 24.0% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | -11.6% | — | ||
| Q1 25 | -11.0% | — | ||
| Q4 24 | -29.7% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | 53.5% | — | ||
| Q1 24 | — | — |
资本支出强度INSGRIGL
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率INSGRIGL
| Q4 25 | 25.50× | 0.08× | ||
| Q3 25 | 2.22× | 0.86× | ||
| Q2 25 | -8.81× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.65× | 1.75× | ||
| Q2 24 | 44.31× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
